$1.45
At close: Apr 11, 3:59 PM EDT
Comments
Loading...
Innate Pharma Earnings Estimates, EPS & Revenue | OTC:IPHYF | Benzinga
Innate Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$24.85M
Analyze the earnings history of Innate Pharma using advanced sorting and filters.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data available to display | ||||||||||||
Innate Pharma (IPHYF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Innate Pharma (IPHYF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Innate Pharma (OTCPK:IPHYF) reporting earnings?
There are no earnings for Innate Pharma
What were the latest earnings per share (EPS) for Innate Pharma (OTCPK:IPHYF)?
There are no earnings for Innate Pharma
What were Innate Pharma’s (OTCPK:IPHYF) revenues?
There are no earnings for Innate Pharma
Browse earnings estimates, EPS, and revenue on all stocks.
